Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prokidney (PROK) Liabilities and Shareholders Equity (2022 - 2025)

Historic Liabilities and Shareholders Equity for Prokidney (PROK) over the last 4 years, with Q3 2025 value amounting to $351.6 million.

  • Prokidney's Liabilities and Shareholders Equity fell 2594.5% to $351.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 billion, marking a year-over-year decrease of 1186.1%. This contributed to the annual value of $441.1 million for FY2024, which is 487.95% up from last year.
  • Latest data reveals that Prokidney reported Liabilities and Shareholders Equity of $351.6 million as of Q3 2025, which was down 2594.5% from $372.1 million recorded in Q2 2025.
  • In the past 5 years, Prokidney's Liabilities and Shareholders Equity ranged from a high of $532.4 million in Q3 2022 and a low of $250.8 million during Q1 2022
  • In the last 4 years, Prokidney's Liabilities and Shareholders Equity had a median value of $441.1 million in 2024 and averaged $422.4 million.
  • In the last 5 years, Prokidney's Liabilities and Shareholders Equity surged by 9746.62% in 2023 and then plummeted by 2594.5% in 2025.
  • Prokidney's Liabilities and Shareholders Equity (Quarter) stood at $518.0 million in 2022, then dropped by 18.81% to $420.6 million in 2023, then grew by 4.88% to $441.1 million in 2024, then fell by 20.28% to $351.6 million in 2025.
  • Its Liabilities and Shareholders Equity was $351.6 million in Q3 2025, compared to $372.1 million in Q2 2025 and $406.1 million in Q1 2025.